Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
HCA

HCA - HCA Healthcare Inc Stock Price, Fair Value and News

319.70USD+0.27 (+0.08%)Delayed as of 24 Apr 2024, 03:54 pm ET

Market Summary

HCA
USD319.70+0.27
Delayedas of 24 Apr 2024, 03:54 pm
0.08%

HCA Alerts

  • 1 major insider sales recently.

HCA Stock Price

View Fullscreen

HCA RSI Chart

HCA Valuation

Market Cap

84.5B

Price/Earnings (Trailing)

16.12

Price/Sales (Trailing)

1.3

EV/EBITDA

9.49

Price/Free Cashflow

18.03

HCA Price/Sales (Trailing)

HCA Profitability

EBT Margin

11.86%

Return on Equity

494.53%

Return on Assets

9.33%

Free Cashflow Yield

5.55%

HCA Fundamentals

HCA Revenue

Revenue (TTM)

65.0B

Rev. Growth (Yr)

11.65%

Rev. Growth (Qtr)

6.72%

HCA Earnings

Earnings (TTM)

5.2B

Earnings Growth (Yr)

-22.78%

Earnings Growth (Qtr)

48.93%

Breaking Down HCA Revenue

52 Week Range

242.53321.55
(Low)(High)

Last 7 days

1.8%

Last 30 days

-3.2%

Last 90 days

14.5%

Trailing 12 Months

11.6%

How does HCA drawdown profile look like?

HCA Financial Health

Current Ratio

1.18

Debt/Equity

35.07

Debt/Cashflow

0.25

HCA Investor Care

Dividend Yield

0.75%

Dividend/Share (TTM)

2.4

Buy Backs (1Y)

4.50%

Diluted EPS (TTM)

18.96

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202360.9B61.9B63.2B65.0B
202259.7B60.1B59.8B60.2B
202152.6B56.0B58.0B58.8B
202051.7B50.1B50.8B51.5B
201947.8B48.8B50.1B51.3B
201844.4B45.2B46.0B46.7B
201741.1B40.7B40.3B43.6B
201644.3B44.5B44.6B41.5B
201540.8B42.5B43.5B43.6B
201438.4B39.2B40.7B39.3B
201335.9B36.2B35.8B38.0B
201230.7B31.5B33.2B35.9B
201127.9B27.4B27.0B29.7B
201000028.0B
Get all data in R, Python etc through our Historical Stock Data APIs
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of HCA Healthcare Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 20, 2024
wasserman chad j
sold
-289,299
330
-876
svp and cio
Mar 18, 2024
wasserman chad j
acquired
212,436
101
2,100
svp and cio
Mar 18, 2024
wasserman chad j
sold
-110,758
321
-344
svp and cio
Mar 18, 2024
wasserman chad j
sold (taxes)
-400,456
327
-1,224
svp and cio
Feb 16, 2024
cuffe michael s.
acquired
-
-
16,980
evp and chief clinical officer
Feb 16, 2024
sowell joseph a iii
acquired
-
-
6,280
svp; chief development officer
Feb 16, 2024
foster jon m
sold (taxes)
-1,835,870
308
-5,950
evp and coo
Feb 16, 2024
rutherford bill b
sold (taxes)
-2,523,010
308
-8,177
cfo and evp
Feb 16, 2024
hazen samuel n
sold (taxes)
-9,375,910
308
-30,387
ceo
Feb 16, 2024
cuffe michael s.
sold (taxes)
-1,916,710
308
-6,212
evp and chief clinical officer

1–10 of 50

Which funds bought or sold HCA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 22, 2024
Gray Private Wealth, LLC
new
-
375,555
375,555
 0.25%
Apr 22, 2024
Invera Wealth Advisors, LLC
reduced
-0.57
90,163
1,081,410
 0.92%
Apr 22, 2024
Essex Savings Bank
unchanged
-
-
257,136
 0.07%
Apr 22, 2024
Greystone Financial Group, LLC
unchanged
-
81,831
434,256
 0.09%
Apr 22, 2024
Rosenberg Matthew Hamilton
reduced
-5.28
40,515
301,721
 0.09%
Apr 22, 2024
LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE
reduced
-0.55
3,208,720
17,441,600
 3.31%
Apr 22, 2024
Boston Trust Walden Corp
unchanged
-
111,119
589,681
 -%
Apr 22, 2024
ARTHUR M. COHEN & ASSOCIATES, LLC
unchanged
-
56,062
297,509
 0.06%
Apr 22, 2024
Nicholas Hoffman & Company, LLC.
unchanged
-
62,850
333,530
 0.02%
Apr 22, 2024
IFM Investors Pty Ltd
reduced
-1.71
2,398,780
13,760,800
 0.15%

1–10 of 50

Are Funds Buying or Selling HCA?

Are funds buying HCA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own HCA
No. of Funds

HCA Alerts

Unveiling HCA Healthcare Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
frist thomas f jr
25.9%
69,391,032
SC 13G/A
Feb 14, 2024
hercules holding ii
25.7%
68,912,077
SC 13G/A
Feb 13, 2024
vanguard group inc
6.32%
16,929,213
SC 13G/A
Feb 09, 2024
wellington management group llp
3.81%
10,186,129
SC 13G/A
Jan 31, 2024
blackrock inc.
5.4%
14,531,079
SC 13G/A
Feb 14, 2023
frist thomas f jr
24.5%
69,391,032
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
2.5%
7,039,050
SC 13G/A
Feb 14, 2023
hercules holding ii
24.4%
68,912,077
SC 13G/A
Feb 09, 2023
vanguard group inc
6.35%
17,946,718
SC 13G/A
Feb 06, 2023
wellington management group llp
5.08%
14,369,349
SC 13G

Recent SEC filings of HCA Healthcare Inc

View All Filings
Date Filed Form Type Document
Apr 05, 2024
PX14A6G
PX14A6G
Mar 27, 2024
PX14A6G
PX14A6G
Mar 20, 2024
144
Notice of Insider Sale Intent
Mar 20, 2024
4
Insider Trading
Mar 18, 2024
144
Notice of Insider Sale Intent
Mar 15, 2024
ARS
ARS
Mar 15, 2024
DEF 14A
DEF 14A
Mar 15, 2024
DEFA14A
DEFA14A
Feb 26, 2024
8-K
Current Report
Feb 26, 2024
8-K/A
Current Report

Peers (Alternatives to HCA Healthcare Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
UNH
448.5B
371.6B
 -0.74% -0.51%
20.04
1.21
 14.64% 11.24%
CI
103.1B
195.3B
 0.26% 37.72%
19.19
0.53
 8.17% -20.79%
CVS
86.2B
357.8B
 -12.72% -6.73%
10.32
0.24
 10.95% 93.52%
HCA
84.5B
65.0B
 -3.19% 11.59%
16.12
1.3
 7.86% -7.11%
CNC
40.6B
154.0B
 -1.43% 12.08%
15.01
0.26
 6.54% 124.79%
DVA
11.7B
12.1B
 -0.12% 51.97%
16.99
0.97
 4.57% 23.40%
UHS
11.4B
14.3B
 -8.62% 17.22%
15.93
0.8
 6.59% 6.24%
MID-CAP
CHE
9.3B
2.3B
 -4.84% 8.83%
34.2
4.12
 6.06% 9.17%
ACHC
6.5B
2.9B
 -7.52% -4.24%
-301.31
2.23
 12.20% -107.93%
AMN
2.2B
3.8B
 -10.62% -35.16%
10.28
0.57
 -27.73% -52.50%
AMEH
2.1B
1.4B
 -5.65% -0.29%
34.21
1.5
 21.19% 34.42%
SMALL-CAP
ADUS
1.5B
1.1B
 -8.44% -16.43%
24.6
1.45
 11.31% 35.83%
BKD
1.3B
3.0B
 7.61% 59.68%
-6.94
0.44
 6.74% 20.73%
BEAT
53.7M
-
 -3.27% -3.72%
-3.67
-
 - -12.94%
AMS
19.0M
21.3M
 13.26% 5.28%
35.63
0.89
 8.00% -62.25%

HCA Healthcare Inc News

Latest updates
Yahoo Finance • 6 hours ago
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term
Yahoo Finance • 6 hours ago
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
MarketWatch • 23 hours ago
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains
MarketBeat • 25 hours ago
New York State Common Retirement Fund Raises Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)
Nasdaq • 30 hours ago
Should You Buy HCA Healthcare (HCA) Ahead of Q1 Earnings?
MarketWatch • 47 hours ago
HCA Healthcare Inc. stock outperforms competitors on strong trading day
MarketBeat • 22 Apr 2024 • 10:17 am
Wedge Capital Management L L P NC Purchases 13,910 Shares of HCA Healthcare, Inc. (NYSE:HCA)
MarketBeat • 21 Apr 2024 • 06:03 pm
Cetera Trust Company N.A Takes Position in HCA Healthcare, Inc. (NYSE:HCA)
MarketWatch • 19 Apr 2024 • 08:45 pm
HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains
Yahoo Finance • 17 Apr 2024 • 10:15 pm
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market

HCA Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue6.7%17,30316,21315,86115,59115,49714,97114,82014,94515,06415,27614,43513,97714,29313,31111,06812,86113,52312,69412,60212,51712,274
Costs and Expenses2.6%14,95814,58314,05213,66912,19513,26713,06013,13112,47812,11912,31812,00412,22112,3239,50812,05111,91611,71511,40411,05710,785
EBITDA Margin-9.1%0.20*0.22*0.22*0.22*0.22*0.21*0.23*0.24*0.24*0.24*0.20*0.21*---------
Interest Expenses1.7%491483485479453446434408398398386384383385388428438448477461446
Income Taxes36.3%484355397379656360381349581685453393378209344112334215271279244
Earnings Before Taxes43.9%2,3451,6301,8091,9223,3021,7041,7601,8142,5863,1572,1171,9732,0729881,5608101,6079791,1981,4601,489
EBT Margin-13.5%0.12*0.14*0.14*0.14*0.14*0.13*0.16*0.16*0.17*0.16*0.13*0.13*---------
Net Income48.9%1,6071,0791,1931,3632,0811,1341,1551,2731,8142,2691,4501,4231,4266681,0795811,0716127831,0391,064
Net Income Margin-10.8%0.08*0.09*0.09*0.09*0.09*0.09*0.11*0.11*0.12*0.11*0.09*0.09*---------
Free Cashflow13.7%1,5151,3321,2346061,2041,8895504841,2511,3881,4091,334---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets3.0%56,21154,58953,59452,71152,43851,48451,58452,20850,74249,56248,16447,27747,49051,01648,70945,42145,05843,91245,44943,37939,207
  Current Assets4.4%14,92714,29413,88813,54113,64313,48113,93715,00613,54213,24812,47512,03612,33316,26614,03111,01611,19610,76912,86911,10810,213
    Cash Equivalents4.9%9358918628429089998582,3711,4511,0271,1201,0301,7936,5884,6387316215592,430531502
  Inventory-0.4%2,0212,0302,0502,0852,0682,0092,0432,0031,9862,0192,0272,0682,0251,9501,8341,9531,8491,7691,8261,7781,732
  Net PPE2.2%27,71527,11726,64426,05325,57524,97824,58724,22824,06323,54723,47123,18823,19922,94123,07122,98522,71522,00221,46721,12819,757
  Current Liabilities2.0%12,65512,40711,54511,0289,9029,7848,99910,5189,5829,6248,6158,6428,70414,37912,8567,0197,7577,1248,96110,5317,569
  Long Term Debt1.0%37,16936,79336,53736,47837,71437,49238,65736,21034,34232,04932,31930,83830,79530,79230,77934,69933,57734,09734,12031,01932,033
    LT Debt, Current-5.1%2,4242,5532,3952,3783702182461,4862372502532342091721631621451482,0733,796788
    LT Debt, Non Current1.0%37,16936,79336,53736,47837,71437,49238,65736,21034,34232,04932,31930,83830,79530,79230,77934,69933,57734,09734,12031,01932,033
Shareholder's Equity-1,060-461232-73.00--4141,4891,8251,7902,4822,8921,299568------
  Retained Earnings32.0%-1,352-1,989-1,850-2,028-2,280-2,781-3,168-1,589-532-206-121735777-647-1,315-2,394-2,351-3,107-3,474-3,983-4,572
  Additional Paid-In Capital-------------29418588.00------
Accumulated Depreciation0.6%30,83330,65530,02329,41029,18228,75228,22927,81427,28727,14827,22726,68926,11825,83425,41324,87624,52024,29323,90223,45523,208
Shares Outstanding-1.3%266269273276277286293302323328333338---------
Minority Interest0%2,8342,8342,7642,7272,6942,5922,5382,4472,4222,5202,3832,2352,3202,2732,3542,2592,2432,1182,1322,0992,032
Float---61,126---36,171---51,895---25,836---36,403--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations7.9%2,6742,4792,4751,8032,5273,0201,6301,3452,4432,2772,2511,988-3,5832,7178,7231,3752,5052,1261,9979742,175
  Share Based Compensation-20.8%57.0072.0056.0077.0083.0087.0085.0086.0099.0011512997.0013381.0066.0082.0084.0010596.0062.0064.00
Cashflow From Investing-21.7%-1,597-1,312-1,257-1,151-793-546-1,205-845-1,714640-920-649-910-530-808-1,145-1,345-1,262-948-2,165-1,286
Cashflow From Financing8.2%-1,039-1,132-1,198-725-1,838-2,317-1,926425-306-3,003-1,242-2,104-316-245-4,007-109-1,110-2,7318541,216-961
  Dividend Payments-1.2%160162164175156160160177148151156169--1.00152136136137141121
  Buy Backs-21.9%8991,1519248491,5196982,6822,1012,0722,3292,2871,527---441272239242278335

HCA Income Statement

2023-12-31
Consolidated Income Statements - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenues$ 64,968$ 60,233$ 58,752
Salaries and benefits29,48727,68526,779
Supplies9,9029,3719,481
Other operating expenses12,87511,1559,961
Equity in earnings of affiliates(22)(45)(113)
Depreciation and amortization3,0772,9692,853
Interest expense1,9381,7411,566
Losses (gains) on sales of facilities5(1,301)(1,620)
Losses on retirement of debt07812
Total expenses including equity in earnings of affiliates57,26251,65348,919
Income before income taxes7,7068,5809,833
Provision for income taxes1,6151,7462,112
Net income6,0916,8347,721
Net income attributable to noncontrolling interests8491,191765
Net income attributable to HCA Healthcare, Inc.$ 5,242$ 5,643$ 6,956
Per share data:   
Basic earnings per share$ 19.25$ 19.43$ 21.52
Diluted earnings per share$ 18.97$ 19.15$ 21.16
Shares used in earnings per share calculations (in millions):   
Basic272,404290,348323,315
Diluted276,412294,666328,752

HCA Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 935$ 908
Accounts receivable9,9588,891
Inventories2,0212,068
Other2,0131,776
Total current assets14,92713,643
Property and equipment, at cost:  
Land3,1202,799
Buildings21,56020,221
Equipment31,99829,981
Construction in progress1,8701,756
Property and equipment, at cost58,54854,757
Accumulated depreciation(30,833)(29,182)
Property and equipment, net27,71525,575
Investments of insurance subsidiaries477381
Investments in and advances to affiliates756823
Goodwill and other intangible assets9,9459,653
Right-of-use operating lease assets2,2072,065
Other184298
Total assets56,21152,438
Current liabilities:  
Accounts payable4,2334,239
Accrued salaries2,1271,712
Other accrued expenses3,8713,581
Long-term debt due within one year2,424370
Total current liabilities12,6559,902
Long-term debt, less debt issuance costs and discounts of $333 and $30137,16937,714
Professional liability risks1,5571,528
Right-of-use operating lease obligations1,9031,752
Income taxes and other liabilities1,8671,615
Stockholders' equity (deficit):  
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 265,537,300 shares - 2023 and 277,378,300 shares - 202233
Accumulated other comprehensive loss(425)(490)
Retained deficit(1,352)(2,280)
Stockholders' deficit attributable to HCA Healthcare, Inc.(1,774)(2,767)
Noncontrolling interests2,8342,694
Total stockholders' equity (deficit)1,060(73)
Total liabilities and stockholders' equity (deficit)$ 56,211$ 52,438

About HCA Healthcare Inc

HCA
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
 CEO
 WEBSITEhcahealthcare.com
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

HCA Healthcare Inc Frequently Asked Questions

What is the ticker symbol for HCA Healthcare Inc? What does HCA stand for in stocks?

HCA is the stock ticker symbol of HCA Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of HCA Healthcare Inc (HCA)?

As of Tue Apr 23 2024, market cap of HCA Healthcare Inc is 84.49 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HCA stock?

You can check HCA's fair value in chart for subscribers.

What is the fair value of HCA stock?

You can check HCA's fair value in chart for subscribers. The fair value of HCA Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of HCA Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HCA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is HCA Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether HCA is over valued or under valued. Whether HCA Healthcare Inc is cheap or expensive depends on the assumptions which impact HCA Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HCA.

What is HCA Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, HCA's PE ratio (Price to Earnings) is 16.12 and Price to Sales (PS) ratio is 1.3. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HCA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on HCA Healthcare Inc's stock?

In the past 10 years, HCA Healthcare Inc has provided 0.201 (multiply by 100 for percentage) rate of return.